sequence test Market

Company Headquarters: Maryland, US Founded: 1987 Workforce: ~2,500 Company Working: Novavax, Inc. is a biotechnology company that commercializes and develops vaccines to prevent a wide range of infectious diseases. It designs recombinant nanoparticle vaccine technology that produces a strong immune response against a variety of pathogens. It is partnered with leading biopharma organizations, government agencies, research institutions, and foundations, namely the Coalition for Epidemic Preparedness Innovations (US), the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (US), the Serum Institute of India Pvt. Ltd. (India), SK Bioscience (South Korea), CPL Biological (India), and Takeda Pharmaceuticals (US). It has seven research and manufacturing facilities. It has presence in regions namely North America, Europe, and the Middle East and Africa

Company Headquarters: New York, US Founded: 2003 Workforce: ~150 Company Working: Cleveland Biolabs, Inc. is an innovative biopharmaceutical company developing products to address immune system diseases and serious medical needs. It is specialized in offering products such as radiation injury products, immune-oncology, and orphan drugs. It has nine product candidates in its pipeline that have been developing directly through itself or its wholly owned companies, namely Incuron, LLC (US) and Panacela Labs, Inc. (US). It has a proprietary platform, namely the Advanced Immunomodulating Multi-Receptor System (AIMS) platform, which is designed to restore immune homeostasis. Moreover, it has collaboration with government agencies which supports the advanced development and procurement of new medical countermeasures including drugs, vaccines, diagnostics, and medical supplies in order to protect public health from chemical, biological, radiological, and nuclear threats.

Company Headquarters: New York, US Founded: 1995 Workforce: ~50 Company Working: SIGA Technologies (SIGA) is a pharmaceutical business at the commercialization stage that develops and offers antiviral treatments for smallpox, monkeypox, cowpox, and vaccinia complications. The company has an established research and development collaboration with US federal entities. It provides countermeasures to the Strategic National Stockpile (SNS) and the Department of Defense (DoD). TPOXX ("oral TPOXX," also known as "tecovirimat" in certain overseas markets) is the Company's lead product, which it distributes to the US government and international governments (including government-affiliated entities). In addition, the Company sells TPOXX intravenous formulation ("IV TPOXX") to the US Government

Company Headquarters: Ohio, US Founded: 1983 Workforce: ~ 50 Company Working: Navidea Biopharmaceuticals Inc (Navidea) manufacturer and distributor of precision immunodiagnostic agents and immunotherapeutic. It operates through mainly three segments such as diagnostics, therapeutics, and corporate. Tc99m tilmanocept for Kaposi's, NAS, cardiovascular illnesses, sentinel node biopsy, and solid tumors lymphatic mapping, as well as NAV4694 for Alzheimer's Disease, are among its pipeline products. The business is utilizing its Manocept platform to create a variety of precision-targeted solutions that will enhance patient care by locating illness pathways and sites and facilitating accurate clinical decision-making. Furthermore, it operates in the US and the UK.

Company Headquarters: New Jersey, US Founded: 1897 Workforce: ~77,000 Company Working: BD (Becton, Dickinson and Company) is a medical technology company that develops, manufactures, and sells medical devices, instrument systems, and reagents. The company operates in three main segments: BD Medical, BD Life Sciences, and BD Interventional. Its products and services are used in a wide range of medical settings, including hospitals, clinics, and research laboratories. BD's product portfolio includes a wide range of medical devices and instrument systems, including syringes, needles, catheters, diagnostic tests, and imaging systems. The company is also a leader in the development of healthcare software and data analytics solutions. BD's breast biopsy products are designed to improve the accuracy, speed, and safety of breast biopsy procedures, ultimately leading to better patient outcomes. BD has a significant global presence, with operations in over 190 countries around the world. The company has its presence across the Americas, Asia-Pacific, and Europe, and Middle East & Africa regions.

Company Headquarters: London, UK Founded: 1856 Workforce: ~ 17,500 Company Working: Smith+Nephew is a manufacturer and distributor of technologically advanced medical equipment. The company offers products for ENT, sports medicine, advanced wound treatment, orthopedic repair, and trauma. The company offers robotically assisted technologies, hip, and knee implants to replace diseased, worn-out, or injured joints, and trauma-related products to stabilize fractures and deformity restoration procedures. It also provides equipment and supplies for removing and mending soft tissue in addition to products for healing wounds. Smith & Nephew sells its products to a variety of customers, including doctors, nurses, nurse practitioners, surgeons, and buying specialists. In addition, it operates in more than 100 countries worldwide. The company sells its products in Asia, Europe, the Middle East, and Africa. Furthermore, it has operations in North America, Asia Pacific, Latin America, Europe, Middle East, Africa.